Study Results Fuel Avandia Safety Controversy
|
 |
 |
 |
12 December, 2007 04:19 GMT
New research is sparking renewed debate over the safety of the diabetes prescription drug Avandia. In a study of 160,000 patients over the age of 65, those who took Avandia to treat their type 2 diabetes were found to be significantly more susceptible to congestive heart failure, heart attacks and death than those who took other diabetes pills.
|
|
|
|
|
|
|
|
Home 
